The massive shelf and ATM signal severe financial distress. Short-sellers should watch for actual ATM sales (daily volume reveals). Long holders face extreme dilution risk. Expect continued downward pressure as the market prices in future equity issuance. Monitor insider selling and any new drug catalysts that could offset dilution.
KPTI drugs
KPTI drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 5 $9.41entry
- T+1 · 7mo ago −4.14%α −5.53% · $9.02
- T+5 · 6mo ago −5.26%α −7.24% · $8.92
- T+20 · 6mo ago −1.91%α −6.87% · $9.23
- T+60 · 4mo ago −25.50%α −28.24% · $7.01
Price Chart
How similar events traded
Executive Summary
Karyopharm filed a $400M universal shelf registration (including a $100M ATM) representing ~202% of its $198M market cap. The company's auditor flagged substantial doubt about its ability to continue as a going concern, and the massive potential dilution signals severe capital needs. This is a highly dilutive and desperate capital raise for a struggling commercial-stage biotech.
Key Facts
- Filed S-3 shelf for up to $400M in securities (debt, common, preferred, warrants, units)
- Includes a $100M at-the-market (ATM) offering via Jefferies, up to 3% commission
- Stock at $8.40, market cap ~$198M, shelf is 202% of market cap; ATM is ~50%
- Auditors' report includes going concern uncertainty (Ernst & Young, FY2025 10-K)
- Assuming $8.40/share, full ATM draw would issue ~11.9M shares (53% dilution vs 22.6M shares outstanding)
- Net tangible book value per share was -$96.09; after full ATM draw would be -$55.04 per share
- Proceeds for general corporate purposes, no specific use identified
Financial Impact
Up to $400M in potential dilution (~202% of current market cap); $100M ATM alone represents 53% dilution at $8.40/share
Risk Factors
- Dilution of up to 200%+ if full shelf is utilized
- Going concern status, risk of bankruptcy if capital not raised
- ATM sales will pressure stock price mechanically
- No clear revenue growth to absorb dilution
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001193125-26-204130 |
| Document: d69189dex41.htm | 0001193125-26-204130 |
Track record
30 reports on KPTI
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +97.24% at T+60 after the Aug 13, 2026 report. 12 of 13 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.0102 Now $0.0290 +184.31% settles Feb 12
- Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.0102 Now $0.0290 −184.31% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $0.0260 Now $0.0290 +11.54% settles Feb 10
- Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $0.0400 Now $0.0290 −27.50% settles Feb 5
- Nov 5, 202611d ago 8-K Bearish 8/10 Entry $0.0601 Now $0.0290 +51.75% settles Feb 3
- Nov 2, 202614d ago 8-K Bearish 10/10 Entry $0.0883 Now $0.0290 +67.16% settles Feb 1
- Nov 2, 202614d ago 8-K Bearish 7/10 Entry $0.1120 Now $0.0290 +74.11% settles Jan 29
- Oct 28, 202619d ago SC 13G/A Bearish 5/10 Entry $0.8798 Now $0.0290 +96.70% settles Jan 27
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $0.5175 Now $0.0290 +94.40% settles Jan 21
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $0.3150 Now $0.0290 −90.79% settles Jan 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers